Search

Purpose of Review: Cancer patients often have cardiovascular risk factors at the time of cancer diagnosis, which are known to increase the risk of cardiotoxicity. Cancer survivors have significantly higher cardiovascular risk. Current cardiovascular disease prevention guidelines are based on studies that largely excluded these patients. We reviewed recent data regarding cardiovascular disease prevention in this population., Recent Findings: Nonpharmacologic therapies aiming to reduce 'lifestyle toxicity' produced by cancer treatments have demonstrated potential to decrease the incidence of adverse outcomes. Exercise before, during and after cancer treatment not only promotes higher quality of life and cardiorespiratory fitness but also reduces adverse cardiovascular outcomes. Lipid and cardiometabolic disease management is paramount but predominantly based on data that excludes these populations of cancer patients and survivors., Summary: A comprehensive approach including medical evaluation, prescriptive exercise, cardiac risk factor modification, education, counseling, pharmacologic and behavioral interventions are needed in cancer patients. These interventions constitute the core of cardio-oncology rehabilitation programs, which if implemented appropriately may help reduce cardiovascular events in this population. Knowledge gaps in these areas are starting to be addressed by ongoing clinical trials.

Purpose of Review: To discuss the relevant techniques as well as the recent evidence that enhance the understanding of the reader on the applications of cardiovascular magnetic resonance (CMR) in transcatheter aortic valve replacement (TAVR). With different cardiac imaging modalities available as well as the advent of TAVR, it is important to define when CMR can be helpful in the periprocedural evaluation., Recent Findings: The topics of interest covered in this review are CMR evaluation of aortic stenosis/regurgitation, TAVR sizing, vascular measurements for access planning, postimplantation paravalvular regurgitation (PVR), and the potential role of delayed enhancement assessment in patients undergoing TAVR., Summary: CMR is a complementary modality in the assessment of TAVR candidates. The ability of CMR to assess the hemodynamic significance of aortic stenosis and other valvulopathies, as well as to assess accurately the left ventricular ejection fraction and vascular anatomy, makes this technique well rounded. The roles of delayed enhancement for myocardial scar in the evaluation of TAVR candidates and PVR assessment in the postimplant patient are promising, but still yet to be fully defined.